Mineralys Therapeutics, Inc. ( MLYS) - Key Metrics
MLYS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$2.85 | -$0.38 | -$0.38 |
| 2026Q1 | $0 | -$0.47 | -$0.48 | -$0.48 |
| 2025Q4 | $0 | -$0.40 | -$0.47 | -$0.47 |
| 2025Q3 | $0 | -$0.52 | -$0.41 | -$0.41 |
| 2025Q2 | $0 | -$0.66 | -$0.46 | -$0.46 |
MLYS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.37 |
| 2026Q1 | 0% | -14.41 |
| 2025Q4 | 0% | -22.68 |
| 2025Q3 | 0% | -18.23 |
| 2025Q2 | 0% | -5.12 |
MLYS
Price: $25.66
52 week price:
Earnings Per Share: -4.20 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.4 billion